Can oliceridine (TRV130), an ideal novel µ receptor G protein pathway selective (µ-GPS) modulator, provide analgesia without opioid-related adverse reactions?

Ok, Hwoe Gyeong; Kim, Su Young; Lee, Su Jung; Kim, Tae Kyun; Huh, Billy K; Kim, Kyung Hoon

Ok, Hwoe Gyeong; Kim, Su Young; Lee, Su Jung; Kim, Tae Kyun; Huh, Billy K; Kim, Kyung Hoon.

Afiliação

Ok HG; Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University, Yangsan, Korea.
Kim SY; Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University, Yangsan, Korea.
Lee SJ; Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University, Yangsan, Korea.
Kim TK; Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University, Yangsan, Korea.
Huh BK; Department of Pain Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Kim KH; Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University, Yangsan, Korea.

Korean J Pain ; 31(2): 73-79, 2018 Apr.

Article em En | MEDLINE | ID: mdl-29686804

Palavras-chave

Adverse drug reactions; Beta-arrestin 2; G protein-coupled receptors; Intracellular signaling peptides and proteins; Knockout mice; Ligands; Mu opioid receptor; Oliceridine; Opioid analgesics; Patient safety

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Korean J Pain Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Korean J Pain Ano de publicação: 2018 Tipo de documento: Article